Unexpected roles for ADH1 and SORD in catalyzing the final step of erythritol biosynthesis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Szebenyi, Doletha M E
Ortiz, Semira R
Field, Martha S
MetadataShow full item record
AbstractThe low-calorie sweetener erythritol is endogenously produced from glucose through the pentose phosphate pathway in humans. Erythritol is of medical interest because elevated plasma levels of this polyol are predictive for visceral adiposity gain and development of type 2 diabetes. However, the mechanisms behind these associations remain unknown because the erythritol biosynthesis pathway, particularly the enzyme catalyzing the final step of erythritol synthesis (reduction of erythrose to erythritol), is not characterized. In this study, we purified two enzymes from rabbit liver capable of catalyzing the conversion of erythrose to erythritol: alcohol dehydrogenase 1 (ADH1) and sorbitol dehydrogenase (SORD). Both recombinant human ADH1 and SORD reduce erythrose to erythritol, using NADPH as a co-factor, and cell culture studies indicate that this activity is primarily NADPH-dependent. We found that ADH1 variants vary markedly in both their affinity for erythrose and their catalytic capacity (turnover number). Interestingly, the recombinant protein produced from the ADH1B2 variant, common in Asian populations, is not active when NADPH is used as a co-factor in vitro We also confirmed SORD contributes to intracellular erythritol production in human A549 lung cancer cells, where ADH1 is minimally expressed. In summary, human ADH1 and SORD catalyze the conversion of erythrose to erythritol, pointing to novel roles for two dehydrogenase proteins in human glucose metabolism that may contribute to individual responses to diet. Proteomics data are available via ProteomeXchange with identifier PXD015178.
CitationJ Biol Chem. 2019 Nov 1;294(44):16095-16108. doi: 10.1074/jbc.RA119.009049. Epub 2019 Sep 11.
AffiliationHIRI, Helmholtz-Institut für RNA-basierte Infektionsforschung, Josef-Shneider Strasse 2, 97080 Würzburg, Germany.
JournalJournal of Biological Chemistry
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Biosynthesis of L-Erythrose by Assembly of Two Key Enzymes in Gluconobacter oxydans.
- Authors: Zou X, Lin J, Mao X, Zhao S, Ren Y
- Issue date: 2017 Sep 6
- Mammalian metabolism of erythritol: a predictive biomarker of metabolic dysfunction.
- Authors: Ortiz SR, Field MS
- Issue date: 2020 Sep
- Identification, characterization of two NADPH-dependent erythrose reductases in the yeast Yarrowia lipolytica and improvement of erythritol productivity using metabolic engineering.
- Authors: Cheng H, Wang S, Bilal M, Ge X, Zhang C, Fickers P, Cheng H
- Issue date: 2018 Aug 29
- Molecular cloning and biochemical characterization of a novel erythrose reductase from Candida magnoliae JH110.
- Authors: Lee DH, Lee YJ, Ryu YW, Seo JH
- Issue date: 2010 Jun 8
- Characterization of erythrose reductase from Yarrowia lipolytica and its influence on erythritol synthesis.
- Authors: Janek T, Dobrowolski A, Biegalska A, Mirończuk AM
- Issue date: 2017 Jul 11